Difference between revisions of "Research:MRNA vaccine"
Jump to navigation
Jump to search
(filled out Research section) |
(formatting) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== Research == | == Research == | ||
=== | === Variants and synonyms === | ||
* | * | ||
===Definition/description=== | ===Definition/description=== | ||
In addition, the induction of an effective immune response requires stimulation of the innate immune system by the mRNA vaccine. | In addition, the induction of an effective immune response requires stimulation of the innate immune system by the mRNA vaccine. | ||
Source: https://doi.org/10.3389/fimmu.2018.01963 | <small>Source: https://doi.org/10.3389/fimmu.2018.01963</small> | ||
These results indicate that non-replicating mRNA vaccines potently induce an immunological repertoire associated with the generation of high magnitude long-lived antibodies. | These results indicate that non-replicating mRNA vaccines potently induce an immunological repertoire associated with the generation of high magnitude long-lived antibodies. | ||
Source: https://doi.org/10.3389/fimmu.2018.01963 | <small>Source: https://doi.org/10.3389/fimmu.2018.01963</small> | ||
===Examples=== | ===Examples=== | ||
<blockquote>Moderna reports that mRNA-1273 is an '''mRNA vaccine''' targeting a prefusion-stabilized form of the S protein associated with SARS-CoV-2, which was selected by Moderna in collaboration with investigators at the NIAID Vaccine Research Center. </blockquote><small>Source: https://doi.org/10.1021/acscentsci.0c00272</small> | |||
Source: https://doi.org/10.1021/acscentsci.0c00272 | |||
=== Collocations === | === Collocations === | ||
* manufacture | * manufacture mRNA vaccine | ||
* engineer | * engineer mRNA vaccine | ||
* optimize | * optimize mRNA vaccine | ||
* formulate | * formulate mRNA vaccine | ||
* administer | * administer mRNA vaccine | ||
* deliver | * deliver mRNA vaccine | ||
* employ | * employ mRNA vaccine | ||
* compose | * compose mRNA vaccine | ||
* test | * test mRNA vaccine | ||
* | * mRNA vaccine protect | ||
* | * mRNA vaccine feature | ||
* | * mRNA vaccine offer | ||
* | * mRNA vaccine induce | ||
* | * mRNA vaccine target | ||
* effective | * effective mRNA vaccine | ||
* potent | * potent mRNA vaccine | ||
* conventional | * conventional mRNA vaccine | ||
* | * | ||
===Keyness=== | ===Keyness=== | ||
> 1000 | >1000 | ||
Latest revision as of 19:50, 7 March 2022
Research
Variants and synonyms
Definition/description
In addition, the induction of an effective immune response requires stimulation of the innate immune system by the mRNA vaccine.
Source: https://doi.org/10.3389/fimmu.2018.01963
These results indicate that non-replicating mRNA vaccines potently induce an immunological repertoire associated with the generation of high magnitude long-lived antibodies.
Source: https://doi.org/10.3389/fimmu.2018.01963
Examples
Moderna reports that mRNA-1273 is an mRNA vaccine targeting a prefusion-stabilized form of the S protein associated with SARS-CoV-2, which was selected by Moderna in collaboration with investigators at the NIAID Vaccine Research Center.
Source: https://doi.org/10.1021/acscentsci.0c00272
Collocations
- manufacture mRNA vaccine
- engineer mRNA vaccine
- optimize mRNA vaccine
- formulate mRNA vaccine
- administer mRNA vaccine
- deliver mRNA vaccine
- employ mRNA vaccine
- compose mRNA vaccine
- test mRNA vaccine
- mRNA vaccine protect
- mRNA vaccine feature
- mRNA vaccine offer
- mRNA vaccine induce
- mRNA vaccine target
- effective mRNA vaccine
- potent mRNA vaccine
- conventional mRNA vaccine
Keyness
>1000